StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.01−0.38 (-0.79%)

Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%

Conmed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Conmed's operating income for the twelve months ending Sep 30, 2026 was $135.59M, up 14.4% year over year. For fiscal 2025 it was $102.62M, down 48.8% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $200.33M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$102.62M-48.8%
FY2024Dec 31, 2024$200.33M+66.1%
FY2023Dec 31, 2023$120.60M+72.2%
FY2022Dec 31, 2022$70.05M-36.2%
FY2021Dec 31, 2021$109.72M+138.5%
FY2020Dec 31, 2020$46.01M-41.8%
FY2019Dec 31, 2019$79.11M+11.0%
FY2018Dec 31, 2018$71.31M+51.9%
FY2017Dec 31, 2017$46.94M+24.6%
FY2016Dec 31, 2016$37.68M-26.4%
FY2015Dec 31, 2015$51.18M-3.1%
FY2014Dec 31, 2014$52.79M-6.6%
FY2013Dec 31, 2013$56.51M-13.3%
FY2012Dec 31, 2012$65.21M+688.1%
FY2011Dec 31, 2011$8.27M-85.5%
FY2010Dec 31, 2010$57.09M+102.0%
FY2009Dec 31, 2009$28.27M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$37.14M+212.7%
Q2 FY2026Jun 30, 2026$36.41M-4.6%
Q1 FY2026Mar 31, 2026$25.42M+59.3%
Q4 FY2025Dec 31, 2025$36.62M-30.2%
Q3 FY2025Sep 30, 2025$11.88M-81.9%
Q2 FY2025Jun 30, 2025$38.16M-19.0%
Q1 FY2025Mar 31, 2025$15.96M-54.4%
Q4 FY2024Dec 31, 2024$52.50M+4.6%
Q3 FY2024Sep 30, 2024$65.71M+116.9%
Q2 FY2024Jun 30, 2024$47.11M+71.8%
Q1 FY2024Mar 31, 2024$35.01M+175.7%
Q4 FY2023Dec 31, 2023$50.19M–
Q3 FY2023Sep 30, 2023$30.30M+25.0%
Q2 FY2023Jun 30, 2023$27.42M+12.1%
Q1 FY2023Mar 31, 2023$12.70M-43.4%
Q4 FY2022Dec 31, 2022-$1.10M-102.9%
Q3 FY2022Sep 30, 2022$24.25M-9.2%
Q2 FY2022Jun 30, 2022$24.46M-4.9%
Q1 FY2022Mar 31, 2022$22.44M+11.8%
Q4 FY2021Dec 31, 2021$37.22M+50.7%
Q3 FY2021Sep 30, 2021$26.71M-9.1%
Q2 FY2021Jun 30, 2021$25.71M–
Q1 FY2021Mar 31, 2021$20.08M+52.5%
Q4 FY2020Dec 31, 2020$24.70M-11.4%
Q3 FY2020Sep 30, 2020$29.38M+40.3%
Q2 FY2020Jun 30, 2020-$21.25M-213.9%
Q1 FY2020Mar 31, 2020$13.17M+13.2%
Q4 FY2019Dec 31, 2019$27.88M+8.0%
Q3 FY2019Sep 30, 2019$20.94M+81.7%
Q2 FY2019Jun 30, 2019$18.66M+11.8%
Q1 FY2019Mar 31, 2019$11.64M-32.6%
Q4 FY2018Dec 31, 2018$25.82M+11.4%
Q3 FY2018Sep 30, 2018$11.52M-14.5%
Q2 FY2018Jun 30, 2018$16.68M+30.5%
Q1 FY2018Mar 31, 2018$17.28M–
Q4 FY2017Dec 31, 2017$23.18M+83.8%
Q3 FY2017Sep 30, 2017$13.47M–
Q2 FY2017Jun 30, 2017$12.78M–
Q1 FY2017Mar 31, 2017-$2.49M–
Q4 FY2016Dec 31, 2016$12.61M–

More Conmed figures

See a number that looks wrong?